Furthermore, TDP-43 pathology and phosphorylation may be controlled by an unidentified direct or an indirect mechanism, for example the accumulation of TMEM106B, a risk factor for FTD, correlates with insoluble phosphorylated TDP-43 levels in FTLD-TDP type A post-mortem tissue [114]. This evidence concerns the gene TARDBP and frontotemporal dementia.